Overview
Cagrilintide is a long-acting amylin receptor agonist explored in studies of appetite regulation, gastric emptying, and body-weight biology. Designed with an acylated backbone for extended exposure, it’s useful in controlled models that map satiety signals and energy intake over time.
Key research highlights (in plain terms)
-
Amylin pathway activation — engages amylin receptors (calcitonin receptor + RAMP complexes) to study how the brain processes satiety and meal-size signals.
-
Gastric emptying & intake — used in models that track slower gastric emptying and reduced energy intake, linking receptor activity to measurable feeding patterns.
-
Extended pharmacology — acylation supports longer circulating time, enabling time-course studies and exposure–response curves under standardized conditions.
-
Combination models — often paired in research with GLP-1 pathway agonists to examine complementary mechanisms in appetite and weight-biology experiments.
-
Dose–response & selectivity — suited for profiling potency, receptor selectivity, and downstream marker panels in a controlled setting.
Why Pegasus
-
Clarity in every vial: straightforward specs and labeling
Specifications
-
Form: Lyophilized powder
-
Identity: Amylin-receptor agonist (research grade)
-
Appearance: White to off-white
-
Purity: no third-party certificate is currently published for this product
-
Solubility: Sterile water or appropriate buffer (optimize per protocol)
-
Packaging: Labeled vial
Storage & handling
-
Store dry at −20 °C, protected from light and moisture
Included with your order
-
Labeled vial of Cagrilintide (research grade)





